Gabriele Sebastianelli

Neurologist, PhD student at Sapienza University of Rome, Polo Pontino. Passionate about neurology and migraine neurophysiology.

[Gabriele Sebastianelli @Gabriele_Seba]

Differentiating triggers and prodromal symptoms is crucial to shed light on migraine pathophysiology.
Explore the threshold hypothesis in our latest paper on @JCephalalgia 🧠🚀@ppozorosich @CaronnaEdoardo. Thanks @ihs_official for the inspiring iHEAD.
https://t.co/H1ggyNLY7I

[Neurology Journal @GreenJournal]

Each month the Neurology Resident & Fellow Section editorial board selects their favorite article for the month. Read the current pick, "Teaching Video NeuroImages: Status Myoclonus in Severe Hypocalcemia": https://t.co/rPzBsakX7p

#NeurologyRF #NeuroImage

[Neurology Journal @GreenJournal]

🚨 Neurology residents worldwide are invited to apply for a 3‑year term on the Neurology Resident & Fellow Section Editorial Board.

📆 Application deadline: July 13, 2026
🔗 Details: https://t.co/kNYlb8JB25

#NeurologyRF #NeuroTwitter

[Cephalalgia @JCephalalgia]

New in Cephalalgia!
Atogepant reduces migraine frequency and disability regardless of dosing time or meals. Evening use showed greater disability improvement, and intake without food led to larger headache day reduction.
https://t.co/ns4eJu972b
#migraine #headache #brain #pain #neurology #neuroscience
@Luigi_Ian_

@Simona_Sacco_

@Gabriele_Seba

[sikandar adwani @SikandarAdwani]

As a neurologist who sees demyelinating disease, this Continuum issue hit different.

New diagnostic criteria. Three diseases where we once saw one. Drugs that work on smouldering biology for the first time.

I pulled 10 practice-changing points from the AAN Continuum April 2026 MS issue the ones that belong on every neurologist's desk.

Source: Continuum 2026;32(2) — Multiple Sclerosis & Related Disorders.

#NeuroTwitter #MedTwitter

[Gabriele Sebastianelli @Gabriele_Seba]

Is it better to take atogepant in the morning ☀️or in the evening 🌙? Discover the effects of chronotherapy in #migraine in our latest real-world study @Luigi_Ian_ @JCephalalgia, on behalf of the Italian Headache Registry (RICe) Study Group🚀🧠https://t.co/EySo8KCSij

[Cephalalgia @JCephalalgia]

Peer review is one of the most important — and often unseen — pillars of scientific progress.

Congratulations to Dr Gabriele Sebastianelli for being recognised as Outstanding Peer Reviewer for Cephalalgia in 2025.

Your thoughtful, rigorous, and constructive reviews help maintain the highest standards in headache research. Thank you for your dedication to strengthening our scientific community.

#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba

[Gabriele Sebastianelli @Gabriele_Seba]

Peer review is essential for advancing science. Supporting authors and editors in enhancing research quality is both a responsibility and a privilege for every researcher.

Honoured and grateful to @JCephalalgia for this recognition #OutstandingPeerReviewer in 2025 🚀🧠

[International Headache Society @ihs_official]

Peer review is one of the most important — and often unseen — pillars of scientific progress.

Congratulations to Dr Gabriele Sebastianelli for being recognised as Outstanding Peer Reviewer for Cephalalgia in 2025.

Your thoughtful, rigorous, and constructive reviews help maintain the highest standards in headache research. Thank you for your dedication to strengthening our scientific community.

#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba

[Katherine Fu, MD @KatherineFuMD]

🧠📣 Neurology residents - check out this FREE resource for download, a curated collection of 10 learning and 10 teaching cases of the most high yield chief complaints in neurology pulled from published #NeurologyRF cases! 🥳

[Neurology Journal @GreenJournal]

Each month the Neurology Resident & Fellow Section editorial board selects their favorite article for the month. Read their current pick, "Teaching Video NeuroImage: Crossed Vertical Gaze Paresis—A Sign of a Supranuclear Lesion": https://t.co/jg0eX8VrgL

#NeurologyRF

[Neurology Journal @GreenJournal]

Neurology trainees: Tired of searching for cases? Simplify with the #NeurologyRF Bootcamp Booklet—a pocket-sized powerhouse for case-based learning:
✅ 10 learning cases for junior residents
✅ 10 teaching cases for seniors residents

Download yours today: https://t.co/FbOhzg7egc

[Gabriele Sebastianelli @Gabriele_Seba]

@GreenJournal @KatherineFuMD

[Gabriele Sebastianelli @Gabriele_Seba]

Honoured to have contributed to this amazing initiative from #NeurologyRF Bootcamp Booklet for Trainees and Educators | Neurology® Journals https://t.co/4fD7mztOaE

[Headache Journal @HeadacheJournal]

Open Access:
A blink reflex study demonstrates #onabotulinumtoxinA has a potential effect on brainstem #pain processing within the #trigeminal system
https://t.co/6UZbud8HS7
@KristinSoLange @Raffaelli_B et al

[Toxins MDPI @Toxins_MDPI]

#mdpitoxins Editor's Choice Article: "Effects of #Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study".

📞Corresponding author: Dr. Gabriele Sebastianelli

🔎https://t.co/Fjxvpx5vl8

[Neurology Journal @GreenJournal]

Each month the Neurology Resident & Fellow Section editorial board selects their favorite article for the month. Read their current pick, "Clinical Reasoning: A 62-Year-Old Man With Symmetric Saddle Hypoesthesia and Sphincter Dysfunction": https://t.co/SvxPBul1ts

#NeurologyRF

[International Headache Society @ihs_official]

This an editorial linked to the article, Serum GFAP and NfL Levels in Migraine: a Registry for Migraine (REFORM) Study ---which has not published yet.
https://t.co/iqqo6Vw2Yc
#migraine #headache #brain #pain #neurology #neuroscience

[Cephalalgia @JCephalalgia]

This an editorial linked to the article, Serum GFAP and NfL Levels in Migraine: a Registry for Migraine (REFORM) Study ---which has not published yet.
https://t.co/NeViqC0Zsd
#migraine #headache #brain #pain #neurology #neuroscience
@Gabriele_Seba

[nature @Nature]

A drug approved to treat migraine headaches can also alleviate debilitating non-headache symptoms, such as fatigue, brain fog and blinding light sensitivity

https://t.co/OjMcjJYAuw

[International Headache Society @ihs_official]

This study demonstrated the effectiveness of atogepant in preventing migraine after 12-week treatment in real life conditions. Only 3 out of 106 patients discontinued treatment for adverse events.
https://t.co/O84eczwHEJ
#migraine #headache #brain #pain #neurology #neuroscience

[Katherine Fu, MD @KatherineFuMD]

Perivascular radial enhancement is a radiologic hallmark of autoimmune GFAP astrocytopathy, but is this diagnosis on your differential for leptomeningeal enhancement? Check out this #NeurologyRF Pearls & Oy-sters 🦪 for more! https://t.co/rtXtFUM5yH